Manumap
  • Explore
  • Search
  1. Home
  2. Search
  3. Pembrolizumab Versus Chemotherapy For PD-L1–Positive Non–Small-Cell Lung Cancer

Pembrolizumab Versus Chemotherapy For PD-L1–Positive Non–Small-Cell Lung Cancer

·2017·DOI
Health Sciences and Innovation
Biomedical Engineering
Cancer Research and Treatment
Cancer Immunotherapy Advances

Role in the Field

Neutralin Health Sciences and Innovation
Neutralin Biomedical Engineering
Neutralin Cancer Research and Treatment
Neutralin Cancer Immunotherapy Advances

Abstract

Citations

7,026

Year

2017

PageRank

4.9 / 10

Relative influence (log-scaled)

Manumap

Explore the academic research landscape through interactive visualization and discovery tools.

Navigate

  • Explore Map
  • Search Papers
© 2026 Manumap. All rights reserved.